EPICEPT CORP (EPCT) has 15 open-market insider trades by 8 insiders since 2006. The most active filer is Robert G. Savage, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert G. Savage | Dir | — | 4 | $97K | 2007-12-13 |
| Stephane Allard | Chief Medical Officer | — | 1 | $65K | 2012-12-27 |
| John V. Talley | PresDir | — | 2 | $37K | 2007-12-13 |
| Robert W. Cook | CFO-SVPFinance & Admin. | — | 2 | $23K | 2007-12-13 |
| Dileep Bhagwat | SVP-Pharmaceutical Development | — | 3 | $18K | 2007-12-12 |
| Guy C. Jackson | Dir | — | 1 | $13K | 2006-06-13 |
| Oliver Wiedemann | Dir | — | 1 | $7K | 2007-12-12 |
| John F. Bedard | Dir | — | 1 | $3K | 2007-09-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert W. Cook | CFO-SVP & Finance & Admin. | Buy | $7K | 2007-12-13 |
| John V. Talley | President & Director | Buy | $21K | 2007-12-13 |
| Robert G. Savage | Director | Buy | $35K | 2007-12-13 |
| Oliver Wiedemann | Director | Buy | $7K | 2007-12-12 |
| Dileep Bhagwat | SVP-Pharmaceutical Development | Buy | $14K | 2007-12-12 |
| Stephane Allard | Chief Medical Officer | Buy | $65K |
Companies that share insiders with EPCT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2007-09-13 |
| John F. Bedard | Director | Buy | $3K | 2007-09-04 |
| Robert W. Cook | CFO-SVP & Finance & Admin. | Buy | $17K | 2007-08-29 |
| John V. Talley | President & Director | Buy | $16K | 2007-08-28 |
| Dileep Bhagwat | SVP-Pharmaceutical Development | Buy | $2K | 2007-08-24 |
| Dileep Bhagwat | SVP-Pharmaceutical Development | Buy | $2K | 2007-08-23 |
| Robert G. Savage | Director | Buy | $46K | 2007-08-21 |
| Robert G. Savage | Director | Buy | $10K | 2007-08-20 |
| Robert G. Savage | Director | Buy | $6K | 2007-08-17 |
| Guy C. Jackson | Director | Buy | $13K | 2006-06-13 |